These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36004319)

  • 1. Prophylactic and Therapeutic Effect of Kynurenine for Experimental Autoimmune Encephalomyelitis (EAE) Disease.
    Sundaram G; Bessede A; Gilot D; Staats Pires A; Sherman LS; Brew BJ; Guillemin GJ
    Int J Tryptophan Res; 2022; 15():11786469221118657. PubMed ID: 36004319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kynurenine pathway modulation reverses the experimental autoimmune encephalomyelitis mouse disease progression.
    Sundaram G; Lim CK; Brew BJ; Guillemin GJ
    J Neuroinflammation; 2020 Jun; 17(1):176. PubMed ID: 32505212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melatonin ameliorates disease severity in a mouse model of multiple sclerosis by modulating the kynurenine pathway.
    Jand Y; Ghahremani MH; Ghanbari A; Ejtemaei-Mehr S; Guillemin GJ; Ghazi-Khansari M
    Sci Rep; 2022 Sep; 12(1):15963. PubMed ID: 36153399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of Indoleamine-2,3-Dioxygenase and Kynurenine Pathway in Experimental Autoimmune Encephalomyelitis in Mice.
    Zarzecki MS; Cattelan Souza L; Giacomeli R; Silva MRP; Prigol M; Boeira SP; Jesse CR
    Neurochem Res; 2020 Dec; 45(12):2959-2977. PubMed ID: 33040279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of aryl hydrocarbon receptor signaling by a novel agonist ameliorates autoimmune encephalomyelitis.
    Abdullah A; Maged M; Hairul-Islam M I; Osama I A; Maha H; Manal A; Hamza H
    PLoS One; 2019; 14(4):e0215981. PubMed ID: 31026283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential modulation of Ahr and Arid5a: A promising therapeutic strategy for autoimmune encephalomyelitis.
    Alzahrani A; Hanieh H
    Saudi Pharm J; 2020 Dec; 28(12):1605-1615. PubMed ID: 33424253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tryptamine Attenuates Experimental Multiple Sclerosis Through Activation of Aryl Hydrocarbon Receptor.
    Dopkins N; Becker W; Miranda K; Walla M; Nagarkatti P; Nagarkatti M
    Front Pharmacol; 2020; 11():619265. PubMed ID: 33569008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diosgenin ameliorates cellular and molecular changes in multiple sclerosis in C57BL/6 mice.
    Zeinali H; Baluchnejadmojarad T; Roghani M
    Mult Scler Relat Disord; 2021 Oct; 55():103211. PubMed ID: 34425463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of the aryl hydrocarbon receptor and the intrinsic tumoral component of the kynurenine pathway of tryptophan metabolism in primary brain tumors.
    Guastella AR; Michelhaugh SK; Klinger NV; Fadel HA; Kiousis S; Ali-Fehmi R; Kupsky WJ; Juhász C; Mittal S
    J Neurooncol; 2018 Sep; 139(2):239-249. PubMed ID: 29667084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Translocator Protein Ligand PIGA1138 Reduces Disease Symptoms and Severity in Experimental Autoimmune Encephalomyelitis Model of Primary Progressive Multiple Sclerosis.
    Tremolanti C; Cavallini C; Meyer L; Klein C; Da Pozzo E; Costa B; Germelli L; Taliani S; Patte-Mensah C; Mensah-Nyagan AG
    Mol Neurobiol; 2022 Mar; 59(3):1744-1765. PubMed ID: 35018577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 Tat protein attenuates the clinical course of experimental autoimmune encephalomyelitis (EAE).
    Karampoor S; Zahednasab H; Bokharaei-Salim F; Mirzaei R; Mojallal-Tabatabaei Z; Esghaei M; Keyvani H
    Int Immunopharmacol; 2020 Jan; 78():105943. PubMed ID: 31830622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laquinimod arrests experimental autoimmune encephalomyelitis by activating the aryl hydrocarbon receptor.
    Kaye J; Piryatinsky V; Birnberg T; Hingaly T; Raymond E; Kashi R; Amit-Romach E; Caballero IS; Towfic F; Ator MA; Rubinstein E; Laifenfeld D; Orbach A; Shinar D; Marantz Y; Grossman I; Knappertz V; Hayden MR; Laufer R
    Proc Natl Acad Sci U S A; 2016 Oct; 113(41):E6145-E6152. PubMed ID: 27671624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positive allosteric modulation of indoleamine 2,3-dioxygenase 1 restrains neuroinflammation.
    Mondanelli G; Coletti A; Greco FA; Pallotta MT; Orabona C; Iacono A; Belladonna ML; Albini E; Panfili E; Fallarino F; Gargaro M; Manni G; Matino D; Carvalho A; Cunha C; Maciel P; Di Filippo M; Gaetani L; Bianchi R; Vacca C; Iamandii IM; Proietti E; Boscia F; Annunziato L; Peppelenbosch M; Puccetti P; Calabresi P; Macchiarulo A; Santambrogio L; Volpi C; Grohmann U
    Proc Natl Acad Sci U S A; 2020 Feb; 117(7):3848-3857. PubMed ID: 32024760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations of peripheral nerve excitability in an experimental autoimmune encephalomyelitis mouse model for multiple sclerosis.
    Teixeira NB; Picolo G; Giardini AC; Boumezbeur F; Pottier G; Kuhnast B; Servent D; Benoit E
    J Neuroinflammation; 2020 Sep; 17(1):266. PubMed ID: 32894170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphodiesterase 5 inhibition at disease onset prevents experimental autoimmune encephalomyelitis progression through immunoregulatory and neuroprotective actions.
    Pifarré P; Gutierrez-Mecinas M; Prado J; Usero L; Roura-Mir C; Giralt M; Hidalgo J; García A
    Exp Neurol; 2014 Jan; 251():58-71. PubMed ID: 24211383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FTY720, sphingosine 1-phosphate receptor modulator, ameliorates experimental autoimmune encephalomyelitis by inhibition of T cell infiltration.
    Kataoka H; Sugahara K; Shimano K; Teshima K; Koyama M; Fukunari A; Chiba K
    Cell Mol Immunol; 2005 Dec; 2(6):439-48. PubMed ID: 16426494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinematic gait parameters are highly sensitive measures of motor deficits and spinal cord injury in mice subjected to experimental autoimmune encephalomyelitis.
    Fiander MD; Stifani N; Nichols M; Akay T; Robertson GS
    Behav Brain Res; 2017 Jan; 317():95-108. PubMed ID: 27639322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic treatment against GM-CSF, but not IL-17, abolishes relapses in a chronic murine model of multiple sclerosis.
    Uyttenhove C; Gaignage M; Donckers D; Nasr Z; Cheou P; van Snick J; D'Auria L; van Pesch V
    Eur J Immunol; 2018 Nov; 48(11):1883-1891. PubMed ID: 30216414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laquinimod protects the optic nerve and retina in an experimental autoimmune encephalomyelitis model.
    Wilmes AT; Reinehr S; Kühn S; Pedreiturria X; Petrikowski L; Faissner S; Ayzenberg I; Stute G; Gold R; Dick HB; Kleiter I; Joachim SC
    J Neuroinflammation; 2018 Jun; 15(1):183. PubMed ID: 29903027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.